Fate Therapeutics Inc
FATE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001434316
In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Fate Therapeutics Inc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 159 | 3 | 132 | −24 |
| Shares | 101.7M | 317.7K | 96.6M | −4.79M (−4.7%) |
| Value | $166.5M | $524.1K | $76.3M | −$89.6M (−54.0%) |
3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Fate Therapeutics Inc at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 7,794,513 | $6.16M | 0.04% |
| Nuveen, LLC | 379,088 | $299.5K | 0.00% |
| Callan Family Office, LLC | 82,024 | $64.8K | 0.00% |
| Ieq Capital, LLC | 74,506 | $58.9K | 0.00% |
| SEI Investments Co | 67,843 | $53.6K | 0.00% |
| Caption Management, LLC | 57,000 | $45.0K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 29,909 | $23.6K | 0.00% |
| CIBC World Markets Corp | 22,214 | $17.6K | 0.00% |
| Tiaa Trust, National Association | 17,592 | $13.9K | 0.00% |
| Captrust Financial Advisors | 16,429 | $13.0K | 0.00% |
| Pallas Capital Advisors LLC | 14,232 | $11.2K | 0.00% |
| Simplex Trading, LLC | 14,380 | $11.0K | 0.00% |
| Financial Engines Advisors L.L.C. | 10,073 | $7.93K | 0.00% |
| UMA Financial Services, Inc. | 1,094 | $865 | 0.00% |
| True Wealth Design, LLC | 921 | $728 | 0.00% |
| Coldstream Capital Management Inc | 686 | $542 | 0.00% |
| CoreCap Advisors, LLC | 255 | $201 | 0.00% |
| Smartleaf Asset Management LLC | 35 | $29 | 0.00% |
Sold out (42)
Institutions that held Fate Therapeutics Inc at the end of Q4 2024 and filed for Q1 2025 without it.
Not filed for Q1 2025 yet (3)
Institutions that held Fate Therapeutics Inc at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 317,271 | $523.5K |
| Hilltop National Bank | 285 | $470 |
| Legacy Investment Solutions, LLC | 115 | $147 |